Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease.
Medicare will cover new class of Alzheimer's drugs if fully approved by FDA, with limits Jun 2, 2023 The real costs of the new Alzheimer's drug, most of which will fall to taxpayers Aug 14, 2023 ...
A simple blood test could detect Alzheimer’s disease with 100% accuracy, according to research from Resonant, a Utah biotech ...
Two North Carolina universities are conducting clinical trials involving a Food and Drug Administration-approved drug for Alzheimer’s, and they need volunteers to test it out. The new AHEAD ...
BLUFFTON, S.C. (WCSC) - One of the first Alzheimer’s patients in the Lowcountry to take part in Leqembi infusion treatments ...
American mortality is at the youngest it has been in almost two decades. But could repurposing a decades-old diabetes drug ...
Just four months after the Food and Drug Administration gave full approval to a new Alzheimer’s drug, it’s estimated that ...
New treatments and tests for dementia are finally here, after decades of disappointments The post Dementia Breakthroughs ...
One morning in October, US Army Colonel Victor Suarez finished his usual morning workout — a 32-mile bike ride — and then sat ...
The Alzheimer's Disease and Dementia Advisory Council wants state lawmakers to provide $300,000 in state funding for a public ...
TAMPA, Fla. — November is Alzheimer's Awareness Month. It's estimated that 1 in 8 Floridians are currently living with the disease and are supported by more than 800,000 unpaid family caregivers.
BrainSpec, the comprehensive software platform enabling virtual biopsies of the brain, has been awarded clearance by the FDA to begin using their Magnetic Resonance Spectroscopy (MRS) platform to ...
